Announcements

Job offersmore »





Tweeting Growers

Top 5 - yesterday

  • No news has been published yesterday.

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




US: Cannabis Science CEO to speak at Harvard Medical School

Cannabis Science's President, CEO and Co-Founder, Raymond C. Dabney, will be a keynote speaker and panelist at the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017. Additionally, Cannabis Science's Chief Medical Officer (CMO), Allen Herman, will Co-Chair a special session at the GHC Summit. Both Dabney and Herman previously presented at Harvard Medical School in November 2016.

Dabney will be the keynote speaker and a panelist for a special session on "Cannabis Science Versus Cancer and Other Malignancies." Dabney will discuss how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science's vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research.

Additionally, Dabney will present summit participants with an overview of the company's current drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). In addition to co-chairing the session, Herman will participate in the discussion on the epidemiology of cancer and the utilization of opioids in Africa as opioid utilization rates reflect the pain divide. This conference affords Cannabis Science an opportunity to discuss cutting-edge cannabinoid research with some of the greatest minds in modern medicine globally, as well as to network and explore potential partnerships. In addition, through participation in this Summit, Cannabis Science will give updates on progress in the implementation of Cannabis Science's research agreement with Dana-Farber and a potential consortium agreement involving other institutions.

On January 3, 2017, Cannabis Science entered into a CRA with Dana-Farber, one of the world's leading cancer centers. Under the terms of the CRA, Cannabis Science and Dana-Farber will jointly investigate and develop use of cannabinoids to treat various forms of cancers.

"I am excited about Cannabis Science's relationship with Dana-Farber. When I first met Wilfred Ngwa, PhD, Director of Global Health Catalyst at Harvard Medical School and Principal Investigator for the CRA, we immediately realized potential synergies on cancer research interests, and the potential to collaborate to develop cannabinoid-based medicines to treat cancer and control cancer symptoms with minimal side-effects," stated Dabney.

Dabney and Ngwa met during the Constituency for Africa's (CFA) annual Ronald H. Brown African Affairs Series in Washington, DC in September 2016, where they both were on the speaking program. Mr. Dabney is a Member of the Board of Directors of CFA, and the Vice Chairman of CFA's African Healthcare Infrastructure Committee (AHIC).

For more information:
www.globalhealthcatalystsummit.org
cannabisscience.com

Publication date: 3/8/2017

 


 

Other news in this sector:

5/21/2018 "The reintroduction of industrial hemp is in full swing worldwide"
5/18/2018 CAN (BC): Affinor signs agreement with MJ producer license applicant
5/17/2018 CAN (ON): Enniskillen MMJ facility officially opens
5/16/2018 CAN (MB): 120,000 sq. ft. cannabis cultivation operation comes to Winnipeg
5/15/2018 Aurora Cannabis buys MedReleaf for C$3.2 billion
5/15/2018 CAN (QC): 1.5 million sq.ft. Weedon project breaks ground
5/11/2018 "Staffing and managing labor major challenge in cannabis cultivation"
5/10/2018 Record numbers would-be investors for NZ MMJ company
5/10/2018 BC: another 20,000 sq ft MMJ greenhouse planned
5/8/2018 Zimbabwe legalizes cannabis cultivation
5/7/2018 US (CA): Smart Cannabis launches new subsidiary
5/4/2018 Cannabis cultivation begins at High Park Farms
5/3/2018 Police drone spots 15,000 cannabis plants growing on Italian tomato farm
5/3/2018 Australia: The Hydroponics Company acquires botanicals extraction facility
5/3/2018 US (AZ): New owners of Sunizona Greenhouses to cultivate MMJ
5/2/2018 CAN (NB): Zenabis receives cannabis plant sales license
5/1/2018 Scotts Miracle-Gro moves further into marijuana with $450 million deal
4/30/2018 Construction begins on Colombian cannabis cultivation greenhouse
4/27/2018 "Cannabis cultivation will be a race to the bottom"
4/27/2018 Australia: Canopy establishes Asia-Pacific headquarters in Victoria